Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
06/1995
06/15/1995WO1995015749A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/15/1995CA2178476A1 Pretargeting methods and compounds
06/15/1995CA2177495A1 Cysteine protease inhibitors containing heterocyclic leaving groups
06/14/1995EP0657454A1 Imidazopyridazines being angiotensin II antagonists
06/14/1995EP0657452A1 Imidazopyridines
06/14/1995EP0657435A2 1,2-Dihydro-2-oxo-pyrimidines
06/14/1995EP0656889A1 9-chloroprostaglandin esters and amides and their use in the preparation of drugs
06/13/1995US5424448 Preparation of carbonic anhydrase inhibitors
06/13/1995US5424078 Aqueous ophthalmic formulations and methods for preserving same
06/08/1995WO1995015384A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
06/08/1995WO1995015308A1 Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
06/08/1995CA2177699A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
06/07/1995EP0656001A1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
06/07/1995EP0655912A1 Medicaments for the treatment or prevention of elevated intraocular pressure
06/07/1995EP0655911A1 Ophthalmological preparation
06/07/1995CN1103533A Biologically active ureido derivatives useful as antimetastatic agents
06/07/1995CA2137213A1 Imidazopyridines
06/06/1995US5422376 Synthetic viscoelastic material for ophthalmic applications
06/06/1995US5422368 With omega chain having a ring as end group, side effect reduction
06/06/1995US5422359 α-aminoketone derivatives
06/06/1995US5422349 Renin inhibitors
06/01/1995WO1995014683A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
06/01/1995CA2174838A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
05/1995
05/31/1995EP0655460A1 Pharmacotherapeutical use of glutathione derivatives
05/31/1995EP0655442A1 Piperazine derivatives as Tachykinin antagonists
05/31/1995EP0655063A1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension
05/31/1995EP0655058A1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/31/1995EP0655056A1 Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension
05/31/1995EP0655055A1 Tachykinin antagonists
05/30/1995US5420297 Peptides having substance P antagonistic activity
05/30/1995US5420296 Angiogenesis inhibitors and cardiovascular disorders
05/30/1995US5420287 1,2 diarylcyclopentenyl compounds for the treatment of inflammation
05/30/1995US5420138 Bicyclic pyridines which are angiotensin II inhibitors
05/30/1995US5419898 Antiallergic composition for ophthalmic or nasal use
05/30/1995CA2136712A1 Piperazine derivatives
05/30/1995CA2016326C Pyrido-pyridazinone acetic acids for treating chronic diabetic complications
05/26/1995WO1995013830A1 Method for inhibiting angiogenesis using heparinase
05/26/1995WO1995013827A1 A method for preventing or controlling cataract
05/26/1995WO1995013826A1 Preventive and remedy for allergic disease
05/26/1995CA2176934A1 Method for inhibiting angiogenesis using heparinase
05/24/1995EP0653937A1 Chemical compounds
05/24/1995CA2136288A1 Imidazopyridazines
05/18/1995WO1995013262A1 Substituted phenyl compounds
05/18/1995WO1995013064A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
05/18/1995WO1995011682A3 Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents
05/18/1995CA2176363A1 Substituted phenyl compounds
05/18/1995CA2176124A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
05/17/1995EP0652871A1 Benzodiazepine derivatives
05/17/1995EP0652754A1 Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
05/17/1995EP0365613B1 Combination of tobramycin and steroids for topical ophthalmic use
05/16/1995US5416106 Ocular hypotensive agents
05/16/1995US5416084 Benzo-fused thiomorpholinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/11/1995WO1995012611A1 Endothelin receptor antagonists
05/11/1995WO1995012603A1 Matrix metalloprotease inhibitors________________________________
05/11/1995WO1995012581A1 Pseudodipeptide product having an imidazole grouping and applications
05/11/1995WO1995012401A1 Method and means for prevention of cataract
05/11/1995CA2175667A1 Matrix metalloprotease inhibitors________________________________
05/11/1995CA2175595A1 Method and means for prevention of cataract
05/11/1995CA2173875A1 Endothelin receptor antagonists
05/10/1995EP0670729A4 Treating retinal neuronal disorders by the application of insulin-like growth factors and analogs.
05/10/1995EP0651763A1 Oligopeptide collagen derivatives and their use in secondary cataract prevention
05/10/1995EP0651738A1 Natural amino acid derivatives as metalloproteinase inhibitors
05/10/1995EP0651650A1 METHOD OF TREATING OPHTHALMIC DISORDERS USING TGF-$g(b)
05/09/1995US5414011 Preservative system for ophthalmic formulations
05/09/1995US5414009 Azabicyclo substituted oxa- or thia-diazole compounds
05/09/1995US5413998 Benzo-fused thiazopinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/04/1995WO1995011883A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
05/04/1995WO1995011682A2 Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents
05/04/1995WO1995011669A1 Suspension of loteprednol etabonate
05/04/1995CA2175076A1 Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents
05/04/1995CA2170736A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
05/03/1995EP0650368A1 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity
05/03/1995EP0327612B1 Pharmaceutical therapeutic use of glutathione derivatives
05/02/1995US5412145 P2'-modified hydroxamic acid collagenase inhibitors
05/02/1995US5411993 Anti-inflammatory, stable aqueous preparation comprising azulene sodium sulfonate and polyhydric alcohol
05/02/1995US5411975 Thiazolidinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411961 Benzo-fused morpholinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411959 1,4-Thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411954 Benzo-fused oxazopinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411953 Oxazopinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411952 Ocular cyclosporine composition
05/02/1995US5411950 Benzo-fused oxazocinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
05/02/1995US5411942 Peptide derivative, pharmaceutical preparation containing it and method for treatment of glaucoma
04/1995
04/27/1995WO1995011229A1 1,11-DIESTERS OF PROSTAGLANDIN-F2α HAVING A POLAR ESTER GROUP AT C-1
04/27/1995WO1995011016A1 R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof
04/27/1995WO1995011003A1 New use of prostaglandins
04/27/1995DE4336051A1 1,2-Dihydro-2-oxopyridines
04/27/1995CA2174655A1 New use of prostaglandins
04/27/1995CA2174241A1 1,11-diesters of prostaglandin-f2.alpha. having a polar ester group at c-1
04/26/1995EP0649418A1 7-(2-aminoethyl)-benzothiazolones
04/26/1995EP0649409A1 Vinyl arenas having retinoid-like activity
04/26/1995CN1102040A Quinoline-3-acetic acid derivative, process for producing the same, and use thereof
04/26/1995CN1101908A Angiotensin II antagonists
04/25/1995US5410075 Non-hygroscopic monoammonium salts of phosphonic and phosphinic acids
04/25/1995US5409947 Treating hypertension, congestive heart failure
04/25/1995US5409945 Benzyo-fused thiazolidinyl terminated alkylamino ethylnyl alanine amino diol compounds for treatment of hypertension
04/25/1995US5409925 Oxazobicyclo terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
04/25/1995US5409924 Benzo-fused oxazobicyclo terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
04/25/1995US5409922 Renin inhibitors
04/25/1995US5409921 Renin inhibitors
1 ... 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 ... 531